Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis (Q57079509)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis	article

Statements

scholarly article

0 references

Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis (English)

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Joerg F. Schlaak

object named as

J Schlaak

4

0 references

author name string

K Hildner

1

0 references

S Finotto

2

0 references

C Becker

3

0 references

P Schirmacher

5

0 references

P R Galle

6

0 references

E Märker-Hermann

7

0 references

M F Neurath

8

0 references

language of work or name

0 references

publication date

October 1999

0 references

Clinical and Experimental Immunology

0 references

118

0 references

1

0 references

137-46

0 references

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Biologic agents for treating rheumatoid arthritis. Concepts and progress

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Molecular therapeutics. Methotrexate and its mechanism of action

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

TNF alpha--a pivotal role in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Th1/Th2 cytokine balance in arthritis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.1999.01022.X

21 January 2018

Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

The biology of cachectin/TNF--a primary mediator of the host response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905404

2 November 2018

Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of methotrexate and 7-hydroxymethotrexate on rat adjuvant arthritis and on urinary aminoimidazole carboxamide excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the effect of low dose methotrexate on rat adjuvant arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the effect of methotrexate on macrophage function

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of methotrexate on the production and activity of interleukin-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate pharmacokinetics in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of cytokine gene expression in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate inhibits proliferation but not interleukin 1 stimulated secretory activities of cultured human synovial fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/10540171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2249.1999.01022.X

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57079509&oldid=1568019266"